Search Within

GDMT, Medicine

Formats
  1. Journal Article (929)
  2. Meeting Abstract (829)
  3. Review (49)
  4. Book Section (38)
  5. Editorial (29)
  6. Guidelines (19)
  7. Correspondence (7)
  8. Research Letter (1)
Groups
  1. Gynecology Disease Management Team (1901)
  2. Department of Medicine (1890)
  3. Solid Tumor Oncology Division (1890)
  4. Gynecologic Medicine Service (1850)
  5. Surgery (582)
  6. GDMT, Surgery (465)

More Groups

People
  1. Carol Aghajanian (613)
  2. Martee Hensley (290)
  3. Nadeem Abu-Rustum (279)
  4. Roisin O'Cearbhaill (272)
  5. Vicky Makker (267)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (64)
  2. 2024 (159)
  3. 2023 (165)
  4. 2022 (196)
  5. 2021 (146)
  6. 2020 (173)

More Years

Publications
  1. Journal of Clinical Oncology (418)
  2. Gynecologic Oncology (416)
  3. International Journal of Gynecological Cancer (152)
  4. Annals of Oncology (106)
  5. Clinical Cancer Research (64)
  6. Cancer (37)

More Publications

Publishers
  1. Elsevier Inc. (496)
  2. American Society of Clinical Oncology (450)
  3. Lippincott Williams & Wilkins (177)
  4. American Association for Cancer Research (139)
  5. Oxford University Press (128)
  6. Nature Publishing Group (73)

More Publishers

Results (1901)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic evolution of uterine leiomyosarcoma: A study of serial recurrences
    Meeting Abstract

    Sia, T.; Miller, K.; Brown, D.; Selenica, P.; Paula, A. D.; Abu-Rustum, N.; Leitao, M.; Chiang, S.; Weigelt, B.; Hensley, M.
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • The genomic landscape of distant metastatic endometrial cancer
    Meeting Abstract

    Zammarrelli, B.; Nandakumar, S.; Kertowidjojo, E.; Nguygen, B.; Paula, A. D.; Rios-Doria, E.; Smith, S.; Momeni-Boroujeni, A.; Aghajanian, C.; Mueller, J.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • A randomized, phase II/III study of pegylated-liposomal-doxorubicin and atezolizumab (IND #134427) versus pegylated-liposomal-doxorubicin, bevacizumab and atezolizumab versus pegylated-liposomal-doxorubicin and bevacizumab in platinum-resistant ovarian cancer (NRG-GY009)
    Meeting Abstract

    O'Cearbhaill, R.; Sill, M.; Duong, H.; Waggoner, S.; Grisham, R.; Backes, F.; Mannel, R.; Tanyi, J.; Powell, M.; Mathews, C.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Selinexor maintenance for patients with TP53WT advanced or recurrent endometrial cancer: Long-term follow up of efficacy and safety subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
    Meeting Abstract

    Scambia, G.; Vergote, I.; Hamilton, E.; Fidalgo, J. P.; Van Gorp, T.; Sehouli, J.; Klat, J.; Levy, T.; Welch, S.; Richardson, D.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Efficacy and safety of trastuzumab deruxtecan in patients with HER2-expressing solid tumors: Results from the cervical, endometrial, and ovarian cancer cohorts of the destiny-PanTumor02 study
    Meeting Abstract

    Lee, J. Y.; Makker, V.; Manso, L.; González-Martín, A.; Lugowska, I.; Lorusso, D.; Banerjee, S.; Liao, J.; Lu, C. H.; Prasongsook, N.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Ubamatamab (MUC16XCD3 bispecific antibody) with or without cemiplimab (anti-PD-1 antibody) in recurrent ovarian cancer: Phase 1 clinical and biomarker results
    Meeting Abstract

    Liu, J.; O'Malley, D.; Van Nieuwenhuysen, E.; Moore, K.; Hamilton, E.; Yeku, O.; Bouberhan, S.; Hou, J.; Schröder, D.; Wang, B.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Durvalumab with paclitaxel/carboplatin + bevacizumab then maintenance durvalumab, bevacizumab + olaparib in patients with newly diagnosed advanced ovarian cancer without a tumour brca1/2 mutation: Results from the DUO-O/ENGOT-OV46/AGO-OVAR 23/GOG-3025 trial
    Meeting Abstract

    Marth, C.; Park-Simon, T. W.; Aghajanian, C.; Reuss, A.; Nishio, S.; Lim, M. C.; Rubio-Pérez, M. J.; Vardar, M. A.; Scambia, G.; Sabatier, R.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Efficacy and safety of avutometinib plus defactinib in recurrent low-grade serous ovarian cancer following prior systemic therapy
    Meeting Abstract

    Grisham, R.; Aghajanian, C.; Van Nieuwenhuysen, E.; Rodrigues, M.; Ring, K.; Santin, A.; Colombo, N.; Prendergast, E.; Thaker, P.; Moore, K.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Oncologic outcomes of sentinel lymph node mapping versus lymph node dissection in staging of apparent uterine-confined clear cell carcinoma
    Meeting Abstract

    Dagher, C.; Sassine, D.; Abu-Rustum, N. R.; Mueller, J. J.; Borach, V.; Zivanovic, O.; Sonoda, Y.; Friedman, C.; Leitao, M. M.
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Long-term follow up of selinexor maintenance for patients with TP53wt advanced or recurrent endometrial cancer: A pre-specified subgroup analysis from the phase 3 Engot-En5/ GOG-3055/SIENDO Study
    Meeting Abstract

    Fidalgo, A. P.; Vergote, I.; Hamilton, E.; Valabrega, G.; Van Gorp, T.; Sehouli, J.; Klat, J.; Levy, T.; Welch, S.; Richardson, D. L.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save